<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34783031</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><Volume>179</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> mice.</ArticleTitle><Pagination><StartPage>1732</StartPage><EndPage>1752</EndPage><MedlinePgn>1732-1752</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.15738</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by the degeneration of upper and lower motor neurons, progressive wasting and paralysis of voluntary muscles and is currently incurable. Although considered to be a pure motor neuron disease, increasing evidence indicates that the sole protection of motor neurons by a single targeted drug is not sufficient to improve the pathological phenotype. We therefore evaluated the therapeutic potential of the multi-target drug used to treatment of coronary artery disease, trimetazidine, in SOD1<sup>G93A</sup> mice.</AbstractText><AbstractText Label="EXPERIMENTAL APPROACH">As a metabolic modulator, trimetazidine improves glucose metabolism. Furthermore, trimetazidine enhances mitochondrial metabolism and promotes nerve regeneration, exerting an anti-inflammatory and antioxidant effect. We orally treated SOD1<sup>G93A</sup> mice with trimetazidine, solubilized in drinking water at a dose of 20&#x2009;mg&#x2009;kg<sup>-1</sup> , from disease onset. We assessed the impact of trimetazidine on disease progression by studying metabolic parameters, grip strength and histological alterations in skeletal muscle, peripheral nerves and the spinal cord.</AbstractText><AbstractText Label="KEY RESULTS">Trimetazidine administration delays motor function decline, improves muscle performance and metabolism, and significantly extends overall survival of SOD1<sup>G93A</sup> mice (increased median survival of 16&#x2009;days and 12.5&#x2009;days for male and female respectively). Moreover, trimetazidine prevents the degeneration of neuromuscular junctions, attenuates motor neuron loss and reduces neuroinflammation in the spinal cord and in peripheral nerves.</AbstractText><AbstractText Label="CONCLUSION AND IMPLICATIONS">In SOD1<sup>G93A</sup> mice, therapeutic effect of trimetazidine is underpinned by its action on mitochondrial function in skeletal muscle and spinal cord.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scaricamazza</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7177-9459</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvatori</LastName><ForeName>Illari</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9700-1269</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Roma "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amadio</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9266-4597</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesci</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torcinaro</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9436-8783</Identifier><AffiliationInfo><Affiliation>National Council of Research (CNR), Institute of Cell Biology and Neurology (IBCN), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacovazzo</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7430-2835</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Primiano</LastName><ForeName>Aniello</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9415-9175</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Molecular Biology Clinic, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Molecular Biology Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gloriani</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candelise</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5086-3996</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieroni</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7141-1817</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-0166-5496</Identifier><AffiliationInfo><Affiliation>Centre de Recherche de Biom&#xe9;decine de Strasbourg (CRBS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM, U1118, Central and Peripheral Mechanisms of Neurodegeneration, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren&#xe8;</LastName><ForeName>Frederique</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7484-5936</Identifier><AffiliationInfo><Affiliation>Centre de Recherche de Biom&#xe9;decine de Strasbourg (CRBS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM, U1118, Central and Peripheral Mechanisms of Neurodegeneration, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quessada</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de Recherche de Biom&#xe9;decine de Strasbourg (CRBS), Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM, U1118, Central and Peripheral Mechanisms of Neurodegeneration, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tefera</LastName><ForeName>Tesfaye W</ForeName><Initials>TW</Initials><Identifier Source="ORCID">0000-0001-5203-2299</Identifier><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8574-7327</Identifier><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0002-4782-3608</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0002-1388-2108</Identifier><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrowolny</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8693-0724</Identifier><AffiliationInfo><Affiliation>DAHFMO-Unit of Histology and Medical Embryology, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, University of Roma "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepore</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>DAHFMO-Unit of Histology and Medical Embryology, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, University of Roma "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9168-3174</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Biochemistry and Molecular Biology Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musar&#xf2;</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2944-9739</Identifier><AffiliationInfo><Affiliation>DAHFMO-Unit of Histology and Medical Embryology, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, University of Roma "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volont&#xe9;</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7362-8307</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute for Systems Analysis and Computer Science (IASI), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9596-4624</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coccurello</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7059-7015</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute for Complex System (ISC), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valle</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0914-6511</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4097-0605</Identifier><AffiliationInfo><Affiliation>Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>N9A0A0R9S8</RegistryNumber><NameOfSubstance UI="D014292">Trimetazidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014292" MajorTopicYN="Y">Trimetazidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1G93A mice</Keyword><Keyword MajorTopicYN="N">Trimetazidine</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">hypermetabolism</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34783031</ArticleId><ArticleId IdType="pmc">PMC9305494</ArticleId><ArticleId IdType="doi">10.1111/bph.15738</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander, S. P. , Mathie, A. , Peters, J. A. , Veale, E. L. , Striessnig, J. , Kelly, E. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , Pawson, A. J. , Southan, C. , Davies, J. A. , Aldrich, R. W. , Attali, B. , Baggetta, A. M. , Becirovic, E. , Biel, M. , Bill, R. M. , Catterall, W. A. , &#x2026; Zhu, M. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. British Journal of Pharmacology, 178(S1), S157&#x2013;S245. 10.1111/bph.15539</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15539</ArticleId><ArticleId IdType="pubmed">34529831</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadio, S. , Parisi, C. , Montilli, C. , Carrubba, A. S. , Apolloni, S. , &amp; Volont&#xe9;, C. (2014). P2Yreceptor on the verge of a neuroinflammatory breakdown. Mediators of Inflammation, 2014, 1&#x2013;15. 10.1155/2014/975849</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/975849</ArticleId><ArticleId IdType="pmc">PMC4142314</ArticleId><ArticleId IdType="pubmed">25180027</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoedo, N. D. , Sarlak, S. , Obre, E. , Esteves, P. , B&#xe9;gueret, H. , Kieffer, Y. , Rousseau, B. , Dupis, A. , Izotte, J. , Bellance, N. , Dard, L. , Redonnet&#x2010;Vernhet, I. , Punzi, G. , Rodrigues, M. F. , Dumon, E. , Mafhouf, W. , Guyonnet&#x2010;Dup&#xe9;rat, V. , Gales, L. , Palama, T. , &#x2026; Rossignol, R. (2021). Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. Journal of Clinical Investigation, 131(1). 10.1172/JCI133081</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI133081</ArticleId><ArticleId IdType="pmc">PMC7773363</ArticleId><ArticleId IdType="pubmed">33393495</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni, S. , Caputi, F. , Pignataro, A. , Amadio, S. , Fabbrizio, P. , Ammassari&#x2010;Teule, M. , &amp; Volont&#xe9;, C. (2019). Histamine is an inducer of the heat shock response in SOD1&#x2010;G93A models of ALS. International Journal of Molecular Sciences, 20(15). 10.3390/ijms20153793</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153793</ArticleId><ArticleId IdType="pmc">PMC6696457</ArticleId><ArticleId IdType="pubmed">31382568</ArticleId></ArticleIdList></Reference><Reference><Citation>Argaud, L. , Gomez, L. , Gateau&#x2010;Roesch, O. , Couture&#x2010;Lepetit, E. , Loufouat, J. , Robert, D. , &amp; Ovize, M. (2005). Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia&#x2010;reperfusion injury. Journal of Molecular and Cellular Cardiology, 39(6), 893&#x2013;899. 10.1016/j.yjmcc.2005.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2005.09.012</ArticleId><ArticleId IdType="pubmed">16243351</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal, N. C. , Maurya, S. K. , Sopariwala, D. H. , Sahoo, S. K. , Gupta, S. C. , Shaikh, S. A. , Pant, M. , Rowland L. A., Bombardier, E. , Goonasekera, S. A. , Tupling, A R. , Molkentin, J. D. , &amp; Periasamy, M. (2012). Sarcolipin is a newly identified regulator of muscle&#x2010;based thermogenesis in mammals. Nature Medicine, 18(10), 1575&#x2013;1579. 10.1038/nm.2897</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2897</ArticleId><ArticleId IdType="pmc">PMC3676351</ArticleId><ArticleId IdType="pubmed">22961106</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli, R. , Bonato, A. , De Angelis, L. , Mirabilii, S. , Ricciardi, M. R. , Tafuri, A. , Molfino, A. , Gorini, S. , Leigheb, M. , Costelli, P. , Caruso, M. , Muscaritoli, M. , &amp; Ferraro, E. (2019). Metabolic reprogramming promotes myogenesis during aging. Frontiers in Physiology, 10, 897. 10.3389/fphys.2019.00897</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00897</ArticleId><ArticleId IdType="pmc">PMC6636331</ArticleId><ArticleId IdType="pubmed">31354530</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne, S. E. , Yang, L. , DiMauro, J. P. , Fuller, S. W. , Licata, S. C. , &amp; Beal, M. F. (2006). Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiology of Disease, 22(3), 599&#x2013;610. 10.1016/j.nbd.2006.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.01.001</ArticleId><ArticleId IdType="pubmed">16616851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau, G. , Bauch&#xe9;, S. , Gonzalez de Aguilar, J. L. , Brochier, G. , Mandjee, N. , Tanguy, M.&#x2010;L. , Hussain, G. , Behin, A. , Khiami, F. , Sariali, E. , Hell&#x2010;Remy, C. , Salachas, F. , Pradat, P. F. , Lacomblez, L. , Nicole, S. , Fontaine, B. , Fardeau, M. , Loeffler, J. P. , Meininger, V. , &#x2026; Hanta&#xef;, D. (2015). Endplate denervation correlates with Nogo&#x2010;a muscle expression in amyotrophic lateral sclerosis patients. Annals of Clinical and Translational Neurology, 2(4), 362&#x2013;372. 10.1002/acn3.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot, A. , Za&#xef;di, S. , Iltis, C. , Ribon, M. , Berriat, F. , Schiaffino, L. , Jolly, A. , de la Grange, P. , Mallat, M. , Bohl, D. , Millecamps, S. , Seilhean, D. , Lobsiger, C. S. , &amp; Boill&#xe9;e, S. (2020). Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nature Neuroscience, 23(11), 1339&#x2013;1351. 10.1038/s41593-020-00718-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, J. A. , Southam, K. A. , Blizzard, C. A. , King, A. E. , &amp; Dickson, T. C. (2016). Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Chemical Neuroanatomy, 76, 35&#x2013;47. 10.1016/j.jchemneu.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis, M. J. , Alexander, S. , Cirino, G. , Docherty, J. R. , George, C. H. , Giembycz, M. A. , Hoyer, D. , Insel, P. A. , Izzo, A. A. , Ji, Y. , MacEwan, D. J. , Sobey, C. G. , Stanford, S. C. , Teixeira, M. M. , Wonnacott, S. , &amp; Ahluwalia, A. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175(7), 987&#x2013;993. 10.1111/bph.14153</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14153</ArticleId><ArticleId IdType="pmc">PMC5843711</ArticleId><ArticleId IdType="pubmed">29520785</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paola, E. , Forcina, L. , Pelosi, L. , Pisu, S. , La Rosa, P. , Cesari, E. , Nicoletti, C. , Madaro, L. , Mercatelli, N. , Biamonte, F. , Nobili, A. , D'Amelio, M. , De Bardi, M. , Volpe, E. , Caporossi, D. , Sette, C. , Musar&#xf2;, A. , &amp; Paronetto, M. P. (2020). Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle. Life Science Alliance, 3(10). 10.26508/lsa.201900637</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201900637</ArticleId><ArticleId IdType="pmc">PMC7409371</ArticleId><ArticleId IdType="pubmed">32753528</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedkova, E. N. , Seidlmayer, L. K. , &amp; Blatter, L. A. (2013). Mitochondria&#x2010;mediated cardioprotection by trimetazidine in rabbit heart failure. Journal of Molecular and Cellular Cardiology, 59, 41&#x2013;54. 10.1016/j.yjmcc.2013.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.01.016</ArticleId><ArticleId IdType="pmc">PMC3670593</ArticleId><ArticleId IdType="pubmed">23388837</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhote, V. , &amp; Balaraman, R. (2008). Anti&#x2010;oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia&#x2010;reperfusion injury in rats. Clinical and Experimental Pharmacology and Physiology, 35(5&#x2013;6), 630&#x2013;637. 10.1111/j.1440-1681.2008.04845.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2008.04845.x</ArticleId><ArticleId IdType="pubmed">18318745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny, G. , Lepore, E. , Martini, M. , Barberi, L. , Nunn, A. , Scicchitano, B. M. , &amp; Musar&#xf2;, A. (2018). Metabolic changes associated with muscle expression of SOD1 G93A. Frontiers in Physiology, 9, 1&#x2013;9. 10.3389/fphys.2018.00831</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny, G. , Martini, M. , Scicchitano, B. M. , Romanello, V. , Boncompagni, S. , Nicoletti, C. , Pietrangelo, L. , de Panfilis, S. , Catizone, A. , Bouch&#xe8;, M. , Sandri, M. , Rudolf, R. , Protasi, F. , &amp; Musar&#xf2;, A. (2018). Muscle expression of SOD1 G93A triggers the dismantlement of neuromuscular junction via PKC&#x2010;theta. Antioxidants and Redox Signaling, 28(12), 1105&#x2013;1119. 10.1089/ars.2017.7054</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7054</ArticleId><ArticleId IdType="pubmed">28931313</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolezalova, R. , Lacinova, Z. , Dolinkova, M. , Kleiblova, P. , Haluzikova, D. , Housa, D. , Papezova, H. , &amp; Haluzik, M. (2007). Changes of endocrine function of adipose tissue in anorexia nervosa: Comparison of circulating levels versus subcutaneous mRNA expression. Clinical Endocrinology, 67(5), 674&#x2013;678. 10.1111/j.1365-2265.2007.02944.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2007.02944.x</ArticleId><ArticleId IdType="pubmed">17953628</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi, S. , Gupta, P. , &amp; Kalb, R. G. (2017). Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS&#x2010;like phenotypes in the G93A mutant SOD1 mouse model. Scientific Reports, 7(1), 13150. 10.1038/s41598-017-13304-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13304-4</ArticleId><ArticleId IdType="pmc">PMC5640619</ArticleId><ArticleId IdType="pubmed">29030576</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Gonzalez de Aguilar, J. L. , Echaniz&#x2010;Laguna, A. , Eschbach, J. , Rene, F. , Oudart, H. , Halter, B. , Huze, C. , Schaeffer, L. , Bouillaud, F. , &amp; Loeffler, J. P. (2009). Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE, 4(4), e5390. 10.1371/journal.pone.0005390</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Oudart, H. , Ren&#xe9;, F. , Gonzalez De Aguilar, J. L. , &amp; Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high&#x2010;energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101(30), 11159&#x2013;11164. 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy, A. M. B. , Limjoco, L. L. G. , &amp; Jamora, R. D. G. (2020). Trimetazidine&#x2010;induced parkinsonism: A systematic review. Frontiers in Neurology, 11, 44. 10.3389/FNEUR.2020.00044</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2020.00044</ArticleId><ArticleId IdType="pmc">PMC7052178</ArticleId><ArticleId IdType="pubmed">32158422</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayemendy, P. , Marin, B. , Labrunie, A. , Boirie, Y. , Walrand, S. , Achamrah, N. , Co&#xeb;ffier, M. , Preux, P. M. , Lautrette, G. , Desport, J. C. , Couratier, P. , &amp; J&#xe9;sus, P. (2021). Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. Journal of the Neurological Sciences, 420, 420. 10.1016/j.jns.2020.117257</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117257</ArticleId><ArticleId IdType="pubmed">33290920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri, A. , &amp; Coccurello, R. (2017). What is &#x2018;hyper&#x2019; in the ALS Hypermetabolism? Mediators of Inflammation. Hindawi Limited, 2017, 1&#x2013;11. 10.1155/2017/7821672</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, L. R. , Culver, D. G. , Tennant, P. , Davis, A. A. , Wang, M. , Castellano&#x2010;sanchez, A. , Khan, J. , Polak, M. A. , &amp; Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185, 232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragasso, G. , Piatti Md, P. M. , Monti, L. , Palloshi, A. , Setola, E. , Puccetti, P. , Calori, G. , Lopaschuk, G. D. , &amp; Margonato, A. (2003). Short&#x2010; and long&#x2010;term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. American Heart Journal, 146(5), 854. 10.1016/s0002-8703(03)00415-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-8703(03)00415-0</ArticleId><ArticleId IdType="pubmed">14597947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, X. , Cho, A. , Ciol, M. A. , Pettan&#x2010;Brewer, C. , Snyder, J. , Rabinovitch, P. , &amp; Ladiges, W. (2016). Grip strength is potentially an early indicator of age&#x2010;related decline in mice. Pathobiology of Aging &amp; age&#x2010;Related Diseases, 6(1), 32981. 10.3402/pba.v6.32981</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/pba.v6.32981</ArticleId><ArticleId IdType="pmc">PMC5018066</ArticleId><ArticleId IdType="pubmed">27613499</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacovazzo, G. , Apolloni, S. , &amp; Coccurello, R. (2018). Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation. Purinergic Signalling, 14(3), 299&#x2013;305. 10.1007/s11302-018-9610-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-018-9610-y</ArticleId><ArticleId IdType="pmc">PMC6107461</ArticleId><ArticleId IdType="pubmed">29754194</ArticleId></ArticleIdList></Reference><Reference><Citation>Gontijo, V. S. , Viegas, F. P. D. , Ortiz, C. J. C. , de Freitas Silva, M. , Damasio, C. M. , Rosa, M. C. , Campos, T. G. , Couto, D. S. , Tranches Dias, K. S. , &amp; Viegas, C. (2019). Molecular hybridization as a tool in the design of multi&#x2010;target directed drug candidates for neurodegenerative diseases. Current Neuropharmacology, 18(5), 348&#x2013;407. 10.2174/1385272823666191021124443</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1385272823666191021124443</ArticleId><ArticleId IdType="pmc">PMC7457438</ArticleId><ArticleId IdType="pubmed">31631821</ArticleId></ArticleIdList></Reference><Reference><Citation>

Gurney, M. E.
, 
Pu, H.
, 
Chiu, A. Y.
, 
Canto, M. C. D.
, 
Cynthia, Y.
, 
Alexander, D. D.
, 
Caliendo, J.
, 
Hentati, A.
, 
Kwon, Y. W.
, 
Deng, H. X.
, &amp; 
Siddique, T.
 (1994). Motor neuron degeneration in mice that express a human cu, Zn superoxide dismutase mutation published by: American Association for the Advancement of Science stable. Science, 264(5166), 1772&#x2013;1775. http://www.jstor.org/stable/2883932
</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus, P. , Fayemendy, P. , Nicol, M. , Lautrette, G. , Sourisseau, H. , Preux, P.&#x2010;M. , Desport, J. C. , Marin, B. , &amp; Couratier, P. (2018). Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. European Journal of Neurology, 25(1), 97&#x2013;104. 10.1111/ene.13468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao, Y. , Su, M. , Chen, M. , Jia, W. , Chou, Y. , Huang, Z. , Yang, N. , &amp; Tong, W. (2007). LC/ESI&#x2010;MS method for the determination of trimetazidine in human plasma: Application to a bioequivalence study on Chinese volunteers. Journal of Pharmaceutical and Biomedical Analysis, 43(5), 1804&#x2013;1807. 10.1016/j.jpba.2006.11.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2006.11.040</ArticleId><ArticleId IdType="pubmed">17208404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalucka, J. , Bierhansl, L. , Conchinha, N. V. , Missiaen, R. , Elia, I. , Br&#xfc;ning, U. , Scheinok, S. , Treps, L. , Cantelmo, A. R. , Dubois, C. , de Zeeuw, P. , Goveia, J. , Zecchin, A. , Taverna, F. , Morales&#x2010;Rodriguez, F. , Brajic, A. , Conradi, L. C. , Schoors, S. , Harjes, U. , &#x2026; Carmeliet, P. (2018). Quiescent endothelial cells upregulate fatty acid &#x3b2;&#x2010;oxidation for Vasculoprotection via redox homeostasis. Cell Metabolism, 28(6), 881&#x2013;894.e13. 10.1016/j.cmet.2018.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.07.016</ArticleId><ArticleId IdType="pubmed">30146488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor, P. F. , Lucien, A. , Kozak, R. , &amp; Lopaschuk, G. D. (2000). The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long&#x2010; chain 3&#x2010;ketoacyl coenzyme a thiolase. Circulation Research, 86(5), 580&#x2013;588. 10.1161/01.RES.86.5.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.86.5.580</ArticleId><ArticleId IdType="pubmed">10720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Keon, M. , Musrie, B. , Dinger, M. , Brennan, S. E. , Santos, J. , &amp; Saksena, N. K. (2021). Destination amyotrophic lateral sclerosis. Frontiers in Neurology, 12. 10.3389/fneur.2021.596006</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.596006</ArticleId><ArticleId IdType="pmc">PMC8039771</ArticleId><ArticleId IdType="pubmed">33854469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk, S. E. , Tracey, T. J. , Steyn, F. J. , &amp; Ngo, S. T. (2019). Biomarkers of metabolism in amyotrophic lateral sclerosis. Frontiers in Neurology, 10, 191. 10.3389/fneur.2019.00191</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00191</ArticleId><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuralay, F. , Altekin, E. , Yazlar, A. S. , Onvural, B. , &amp; Goldeli, O. (2006). Suppression of angioplasty&#x2010;related inflammation by pre&#x2010;procedural treatment with trimetazidine. Tohoku Journal of Experimental Medicine, 208(3), 203&#x2013;212. 10.1620/tjem.208.203</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.208.203</ArticleId><ArticleId IdType="pubmed">16498228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilley, E. , Stanford, S. C. , Kendall, D. E. , Alexander, S. P. H. , Cirino, G. , Docherty, J. R. , George, C. H. , Insel, P. A. , Izzo, A. A. , Ji, Y. , Panettieri, R. A. , Sobey, C. G. , Stefanska, B. , Stephens, G. , Teixeira, M. , &amp; Ahluwalia, A. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. British Journal of Pharmacology, 177(16), 3611&#x2013;3616. 10.1111/BPH.15178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BPH.15178</ArticleId><ArticleId IdType="pmc">PMC7393193</ArticleId><ArticleId IdType="pubmed">32662875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopaschuk, G. D. , Barr, R. , Thomas, P. D. , &amp; Dyck, J. R. B. (2003). Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long&#x2010;chain 3&#x2010;ketoacyl coenzyme a thiolase. Circulation Research. Circulation Research, 93, e33&#x2013;e37. 10.1161/01.res.0000086964.07404.a5</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.0000086964.07404.a5</ArticleId><ArticleId IdType="pubmed">12869392</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins, G. F. , de Filho, A. G. S. , de Santos, J. B. F. , Assun&#xe7;&#xe3;o, C. R. C. , Vieira, F. B. , Val&#xea;ncia, A. , Carvalho, K. G. , &amp; Jessen, B. (2012). Trimetazidine and inflammatory response in coronary artery bypass grafting. Arquivos Brasileiros de Cardiologia, 99(2), 688&#x2013;696. 10.1590/S0066-782X2012005000066</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0066-782X2012005000066</ArticleId><ArticleId IdType="pubmed">22790403</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzilli, M. , Vinereanu, D. , Lopaschuk, G. , Chen, Y. , Dalal, J. J. , Danchin, N. , Etriby, E. , Ferrari, R. , Gowdak, L. H. , Lopatin, Y. , Milicic, D. , Parkhomenko, A. , Pinto, F. , Ponikowski, P. , Seferovic, P. , &amp; Rosano, G. M. C. (2019). Trimetazidine in cardiovascular medicine. International Journal of Cardiology, 293, 39&#x2013;44. 10.1016/j.ijcard.2019.05.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.05.063</ArticleId><ArticleId IdType="pubmed">31178223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta, P. R. , Jones, A. R. , Opie&#x2010;Martin, S. , Shatunov, A. , Iacoangeli, A. , Al Khleifat, A. , Smith, B. N. , Topp, S. , Morrison, K. E. , Shaw, P. J. , Shaw, C. E. , Morgan, S. , Pittman, A. , &amp; Al&#x2010;Chalabi, A. (2019). Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias. Journal of Neurology, Neurosurgery, and Psychiatry, 90(3), 268&#x2013;271. 10.1136/jnnp-2018-319089</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319089</ArticleId><ArticleId IdType="pmc">PMC6518463</ArticleId><ArticleId IdType="pubmed">30270202</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, D. , Feng, L. , Chen, X. J. , Yang, D. , &amp; Zhang, J. N. (2006). Trimetazidine improved Ca2+ handling in isoprenaline&#x2010;mediated myocardial injury of rats. Experimental Physiology, 91(3), 591&#x2013;601. 10.1113/expphysiol.2005.032615</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2005.032615</ArticleId><ArticleId IdType="pubmed">16469819</ArticleId></ArticleIdList></Reference><Reference><Citation>Miana&#x2010;Mena, F. J. , Piedrafita, E. , Gonz&#xe1;lez&#x2010;Mingot, C. , Larrod&#xe9;, P. , Mu&#xf1;oz, M. J. , Mart&#xed;nez&#x2010;Ballar&#xed;n, E. , Reiter, R. J. , Osta, R. , &amp; Garc&#xed;a, J. J. (2011). Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis. Journal of Bioenergetics and Biomembranes, 43(2), 181&#x2013;186. 10.1007/s10863-011-9348-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-011-9348-5</ArticleId><ArticleId IdType="pubmed">21451979</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliarini, S. , Scaricamazza, S. , Valle, C. , Ferri, A. , Pasqualetti, M. , &amp; Ferraro, E. (2021). Microglia morphological changes in the motor cortex of hSOD1 G93A transgenic ALS mice. Brain Science, 11. 10.3390/brainsci11060807</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060807</ArticleId><ArticleId IdType="pmc">PMC8234003</ArticleId><ArticleId IdType="pubmed">34207086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra, A. , Rossi, S. , Scaricamazza, S. , Di Salvio, M. , Salvatori, I. , Valle, C. , Rusmini, P. , Poletti, A. , Cestra, G. , Carr&#xec;, M. T. , &amp; Cozzolino, M. (2017). Functional interaction between FUS and SMN underlies SMA&#x2010;like splicing changes in wild&#x2010;type hFUS mice. Scientific Reports, 7(1), 2033. 10.1038/s41598-017-02195-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02195-0</ArticleId><ArticleId IdType="pmc">PMC5435706</ArticleId><ArticleId IdType="pubmed">28515487</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari, F. , Pin, F. , Gorini, S. , Chiandotto, S. , Pontecorvo, L. , Penna, F. , Rizzuto, E. , Pisu, S. , Musar&#xf2;, A. , Costelli, P. , Rosano, G. , &amp; Ferraro, E. (2017). The mitochondrial metabolic reprogramming agent trimetazidine as an &#x2018;exercise mimetic&#x2019; in cachectic C26&#x2010;bearing mice. Journal of Cachexia, Sarcopenia and Muscle, 8(6), 954&#x2013;973. 10.1002/jcsm.12226</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12226</ArticleId><ArticleId IdType="pmc">PMC5700442</ArticleId><ArticleId IdType="pubmed">29130633</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney, E. B. , De Winter, F. , Verhaagen, J. , &amp; Kane, C. J. O. (2014). ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Frontiers in Neuroscience, 8(August), 1&#x2013;18. 10.3389/fnins.2014.00252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo, S. T. , &amp; Steyn, F. J. (2015). The interplay between metabolic homeostasis and neurodegeneration: Insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regeneration, 4, 1&#x2013;14. 10.1186/s13619-015-0019-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13619-015-0019-6</ArticleId><ArticleId IdType="pmc">PMC4551561</ArticleId><ArticleId IdType="pubmed">26322226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo, S. T. , Steyn, F. J. , &amp; Mccombe, P. A. (2014). Journal of the neurological sciences body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 340(1&#x2013;2), 5&#x2013;12. 10.1016/j.jns.2014.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.02.035</ArticleId><ArticleId IdType="pubmed">24629478</ArticleId></ArticleIdList></Reference><Reference><Citation>O'reilly, &#xc9;. J. , Wang, H. , Weisskopf, M. G. , Fitzgerald, K. C. , Falcone, G. , Mccullough, M. L. , Thun, M. , Park, Y. , Kolonel, L. N. , &amp; Ascherio, A. (2013). Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(3), 205&#x2013;211. 10.3109/21678421.2012.735240</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.735240</ArticleId><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggion, C. , Massimino, M. L. , Biancotto, G. , Angeletti, R. , Reggiani, C. , Sorgato, M. C. , Bertoli, A. , &amp; Stella, R. (2017). Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis. Analytical and Bioanalytical Chemistry, 409, 2143&#x2013;2153. 10.1007/s00216-016-0160-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-016-0160-2</ArticleId><ArticleId IdType="pubmed">28078418</ArticleId></ArticleIdList></Reference><Reference><Citation>Percie du Sert, N. , Hurst, V. , Ahluwalia, A. , Alam, S. , Avey, M. T. , Baker, M. , Browne, Wi. J. , Clark, A. , Cuthill, I. C. , Dirnagl, U. , Emerson, M. , Garner, P. , Holgate, S. T. , Howells, D. W. , Karp, N. A. , Lazic, S. E. , Lidster, K. , MacCallum, C. J. , Macleod, M. , &#x2026; Pearl, E. J. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biology, 18(7), e3000410. 10.1371/journal.pbio.3000410</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000410</ArticleId><ArticleId IdType="pmc">PMC7360023</ArticleId><ArticleId IdType="pubmed">32663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov, D. , Mansfield, C. , Moussy, A. , &amp; Hermine, O. (2017). ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Frontiers in Aging Neuroscience, 9(MAR), 1&#x2013;11. 10.3389/fnagi.2017.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Pint&#xe9;r, D. , Bereczki, D. , Ajtay, A. , Oberfrank, F. , Janszky, J. , &amp; Kov&#xe1;cs, N. (2021). Trimetazidine use in Parkinson's disease: Is it a resolved problem? ENeuro, 8(3), ENEURO.0452&#x2013;ENEU20.2021. 10.1523/ENEURO.0452-20.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0452-20.2021</ArticleId><ArticleId IdType="pmc">PMC8143021</ArticleId><ArticleId IdType="pubmed">33863783</ArticleId></ArticleIdList></Reference><Reference><Citation>Poppe, L. , Ru&#xe9;, L. , Robberecht, W. , &amp; Van Den Bosch, L. (2014). Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Experimental Neurology. Academic Press Inc, 262, 138&#x2013;151. 10.1016/j.expneurol.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.001</ArticleId><ArticleId IdType="pubmed">25017368</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes, E. T. , Perurena, O. H. , Festoff, B. W. , Jorgensen, R. , &amp; Moore, W. V. (1984). Insulin resistance in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 63(3), 317&#x2013;324. 10.1016/0022-510X(84)90154-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(84)90154-0</ArticleId><ArticleId IdType="pubmed">6374040</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori, I. , Ferri, A. , Scaricamazza, S. , Giovannelli, I. , Serrano, A. , Rossi, S. , D'Ambrosi, N. , Cozzolino, M. , Giulio, A. D. , Moreno, S. , Valle, C. , &amp; Carr&#xec;, M. T. (2018). Differential toxicity of TAR DNA&#x2010;binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells. Journal of Neurochemistry, 146(5), 585&#x2013;597. 10.1111/jnc.14465</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14465</ArticleId><ArticleId IdType="pubmed">29779213</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori, I. , Valle, C. , Ferri, A. , &amp; Carr&#xec;, M. T. (2017). SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochemistry International, 109, 184&#x2013;192. 10.1016/j.neuint.2017.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.04.012</ArticleId><ArticleId IdType="pubmed">28449871</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza, S. , Salvatori, I. , Ferri, A. , &amp; Valle, C. (2021). Skeletal muscle in ALS: An unappreciated therapeutic opportunity? Cells. NLM (Medline), 10. 10.3390/cells10030525</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030525</ArticleId><ArticleId IdType="pmc">PMC8000428</ArticleId><ArticleId IdType="pubmed">33801336</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza, S. , Salvatori, I. , Giacovazzo, G. , Loeffler, J. P. , Ren&#xe8;, F. , Rosina, M. , Quessada, C. , Proietti, D. , Heil, C. , Rossi, S. , Battistini, S. , Giannini, F. , Volpi, N. , Steyn, F. J. , Ngo, S. T. , Ferraro, E. , Madaro, L. , Coccurello, R. , Valle, C. , &amp; Ferri, A. (2020). Skeletal&#x2010;muscle metabolic reprogramming in ALS&#x2010;SOD1G93A mice predates disease onset and is a promising therapeutic target. IScience, 23(5), 101087. 10.1016/j.isci.2020.101087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101087</ArticleId><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Serarslan, Y. , Bal, R. , Altug, M. E. , Konta&#x15f;, T. , Kele&#x15f;, O. N. , Unal, D. , &amp; Unal, B. (2009). Effects of trimetazidine on crush injury of the sciatic nerve in rats: A biochemical and stereological study. Brain Research, 1247, 11&#x2013;20. 10.1016/j.brainres.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.10.007</ArticleId><ArticleId IdType="pubmed">18983835</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano, A. , Apolloni, S. , Rossi, S. , Lattante, S. , Sabatelli, M. , Peric, M. , Andjus, P. , Michetti, F. , Carr&#xec;, M. T. , Cozzolino, M. , &amp; D'Ambrosi, N. (2019). The S100A4 transcriptional inhibitor Niclosamide reduces pro&#x2010;inflammatory and migratory phenotypes of microglia: Implications for amyotrophic lateral sclerosis. Cell, 8(10). 10.3390/cells8101261</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101261</ArticleId><ArticleId IdType="pmc">PMC6829868</ArticleId><ArticleId IdType="pubmed">31623154</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu, H. , Peng, Y. , Hang, W. , Zhou, N. , &amp; Wang, D. W. (2021). Trimetazidine in heart failure. Frontiers in Pharmacology. Frontiers Media S.A., 11. 10.3389/fphar.2020.569132</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.569132</ArticleId><ArticleId IdType="pmc">PMC7883591</ArticleId><ArticleId IdType="pubmed">33597865</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, E. P. , Henry, Y. K. , Henkel, J. S. , Smith, R. G. , &amp; Appel, S. H. (2004). Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology, 62(10), 1758&#x2013;1765. 10.1212/WNL.62.10.1758</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn, F. J. , Ioannides, Z. A. , Van Eijk, R. P. A. , Heggie, S. , Thorpe, K. A. , Ceslis, A. , Heshmat, S. , Henders, A. K. , Wray, N. R. , van den Berg, L. H. , Henderson, R. D. , McCombe, P. A. , &amp; Ngo, S. T. (2018). Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Journal of Neurology, Neurosurgery and Psychiatry, 89(10), 1016&#x2013;1023. 10.1136/jnnp-2017-317887</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn, F. J. , Li, R. , Kirk, S. E. , Tefera, T. W. , Xie, T. Y. , Tracey, T. J. , Kelk, D. , Wimberger, E. , Garton, F. C. , Roberts, L. , Chapman, S. E. , Coombes, J. S. , Leevy, W. M. , Ferri, A. , Valle, C. , Ren&#xe9;, F. , Loeffler, J. P. , McCombe, P. A. , Henderson, R. D. , &amp; Ngo, S. T. (2020). Altered skeletal muscle glucose&#x2010;fatty acid flux in amyotrophic lateral sclerosis. Brain Communications, 1&#x2013;17. 10.1093/braincomms/fcaa154</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa154</ArticleId><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg, M. S. , Andersen, D. C. , Huntjens, P. , Oklinski, K. E. , Bolther, L. , Hald, J. L. , Baisgaard, A. E. , M&#xf8;rk, K. , Warming, N. , Kullab, U. B. , Kroese, L. J. , Pritchard, C. E. J. , Huijbers, I. J. , &amp; Nieland, J. D. V. (2021). Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Communications Biology, 4(1), 509. 10.1038/s42003-021-02034-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02034-z</ArticleId><ArticleId IdType="pmc">PMC8087699</ArticleId><ArticleId IdType="pubmed">33931719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey, T. J. , Steyn, F. J. , Wolvetang, E. J. , &amp; Ngo, S. T. (2018). Neuronal lipid metabolism: Multiple pathways driving functional outcomes in health and disease. Frontiers in Molecular Neuroscience, 11(January), 1&#x2013;25. 10.3389/fnmol.2018.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787076</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay, A. , Despr&#xe9;s, J. P. , Leblanc, C. , Craig, C. L. , Ferris, B. , Stephens, T. , &amp; Bouchard, C. (1990). Effect of intensity of physical activity on body fatness and fat distribution. The American Journal of Clinical Nutrition, 51(2), 153&#x2013;157. 10.1093/ajcn/51.2.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/51.2.153</ArticleId><ArticleId IdType="pubmed">2305702</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bergh, R. , Swerts, L. , Hendrikx, A. , Boni, L. , &amp; Meulepas, E. (1978). Adipose tissue cellularity in patients with amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery, 80(4), 226&#x2013;240. 10.1016/S0303-8467(78)80013-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0303-8467(78)80013-4</ArticleId><ArticleId IdType="pubmed">216513</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mantgem, J. (2020). Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: A population&#x2010;based study. Journal of Neurology, Neurosurgery, and Psychiatry, 91, 867&#x2013;875. 10.1136/jnnp-2020-322909</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9;, C. , Amadio, S. , Fabbrizio, P. , &amp; Apolloni, S. (2019, October 1). Functional microglia neurotransmitters in amyotrophic lateral sclerosis. Seminars in Cell and Developmental Biology. Elsevier Ltd., 94, 121&#x2013;128. 10.1016/j.semcdb.2019.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.04.014</ArticleId><ArticleId IdType="pubmed">31009755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan, P. , Su, W. , Zhang, Y. , Li, Z. , Deng, C. , &amp; Zhuo, Y. (2017). Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2/ho&#x2010;1 pathway. Clinical Science, 131, 2363&#x2013;2375. 10.1042/CS20171182</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20171182</ArticleId><ArticleId IdType="pmc">PMC5582167</ArticleId><ArticleId IdType="pubmed">28811386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wobst, H. J. , Mack, K. L. , Brown, D. G. , Brandon, N. J. , &amp; Shorter, J. (2020). The clinical trial landscape in amyotrophic lateral sclerosis&#x2014;Past, present, and future. Medicinal Research Reviews. John Wiley and Sons Inc, 40, 1352&#x2013;1384. 10.1002/med.21661</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21661</ArticleId><ArticleId IdType="pmc">PMC7417284</ArticleId><ArticleId IdType="pubmed">32043626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Z. , &amp; Wang, K. K. W. (2015). Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker. Trends in Neurosciences. Elsevier Ltd, 38, 364&#x2013;374. 10.1016/j.tins.2015.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2015.04.003</ArticleId><ArticleId IdType="pmc">PMC4559283</ArticleId><ArticleId IdType="pubmed">25975510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurlo, F. , Larson, K. , Bogardus, C. , &amp; Ravussin, E. (1990). Skeletal muscle metabolism is a major determinant of resting energy expenditure. Journal of Clinical Investigation, 86(November), 1423&#x2013;1427. 10.1172/JCI114857</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI114857</ArticleId><ArticleId IdType="pmc">PMC296885</ArticleId><ArticleId IdType="pubmed">2243122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>